| dna recombination | GO:0006310 | 92 | 1.000 | |
| v d j recombination | GO:0033151 | 14 | 0.999 | |
| telomere capping | GO:0016233 | 4 | 0.999 | |
| dna repair | GO:0006281 | 107 | 0.998 | |
| dna metabolic process | GO:0006259 | 303 | 0.995 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.992 | |
| cellular hyperosmotic salinity response | GO:0071475 | 0 | 0.991 | |
| b cell differentiation | GO:0030183 | 78 | 0.976 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.973 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.967 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.962 | |
| double strand break repair | GO:0006302 | 48 | 0.958 | |
| immature b cell differentiation | GO:0002327 | 10 | 0.942 | |
| non recombinational repair | GO:0000726 | 10 | 0.939 | |
| somatic diversification of immunoglobulins involved in immune response | GO:0002208 | 36 | 0.937 | |
| response to x ray | GO:0010165 | 11 | 0.934 | |
| telomere maintenance | GO:0000723 | 19 | 0.931 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.931 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.925 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.879 | |
| immunoglobulin production | GO:0002377 | 73 | 0.861 | |
| b cell activation | GO:0042113 | 161 | 0.759 | |
| positive regulation of gene silencing by mirna | GO:2000637 | 1 | 0.740 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.718 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.672 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.592 | |
| adaptive immune response | GO:0002250 | 155 | 0.560 | |
| reciprocal dna recombination | GO:0035825 | 16 | 0.554 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.519 | |
| cellular response to radiation | GO:0071478 | 28 | 0.513 | |
| positive regulation of protein oligomerization | GO:0032461 | 4 | 0.501 | |
| somatic diversification of t cell receptor genes | GO:0002568 | 5 | 0.477 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.456 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.419 | |
| intra s dna damage checkpoint | GO:0031573 | 4 | 0.409 | |
| somatic recombination of immunoglobulin genes involved in immune response | GO:0002204 | 36 | 0.407 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 3 | 0.400 | |
| gene silencing | GO:0016458 | 38 | 0.393 | |
| spleen development | GO:0048536 | 39 | 0.378 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.349 | |
| chromatin organization | GO:0006325 | 206 | 0.346 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.337 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.337 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.322 | |
| chromatin silencing | GO:0006342 | 15 | 0.320 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.318 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.316 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.316 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.314 | |
| nucleotide excision repair | GO:0006289 | 13 | 0.310 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.307 | |
| t cell receptor v d j recombination | GO:0033153 | 5 | 0.303 | |
| double strand break repair via nonhomologous end joining | GO:0006303 | 10 | 0.295 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.291 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.280 | |
| dna catabolic process | GO:0006308 | 19 | 0.267 | |
| immunoglobulin production involved in immunoglobulin mediated immune response | GO:0002381 | 43 | 0.263 | |
| replicative senescence | GO:0090399 | 2 | 0.260 | |
| t cell homeostasis | GO:0043029 | 35 | 0.259 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.252 | |
| response to purine containing compound | GO:0014074 | 28 | 0.234 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.232 | |
| signal transduction involved in dna integrity checkpoint | GO:0072401 | 3 | 0.232 | |
| dna damage response signal transduction resulting in transcription | GO:0042772 | 2 | 0.226 | |
| isotype switching | GO:0045190 | 36 | 0.219 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.217 | |
| somatic recombination of t cell receptor gene segments | GO:0002681 | 5 | 0.217 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.213 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.204 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.203 | |
| dendrite regeneration | GO:0031104 | 1 | 0.200 | |
| protection from non homologous end joining at telomere | GO:0031848 | 4 | 0.199 | |
| immunoglobulin v d j recombination | GO:0033152 | 5 | 0.195 | |
| protein maturation | GO:0051604 | 176 | 0.192 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.189 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.181 | |
| pre b cell differentiation | GO:0002329 | 7 | 0.176 | |
| phosphatidylinositol biosynthetic process | GO:0006661 | 15 | 0.174 | |
| meiotic chromosome segregation | GO:0045132 | 19 | 0.172 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.162 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.162 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.161 | |
| dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator | GO:0006978 | 2 | 0.160 | |
| dna catabolic process exonucleolytic | GO:0000738 | 3 | 0.159 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.157 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.154 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.152 | |
| phosphatidylinositol metabolic process | GO:0046488 | 45 | 0.147 | |
| male gamete generation | GO:0048232 | 285 | 0.145 | |
| response to uv | GO:0009411 | 44 | 0.142 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.142 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.136 | |
| regulation of b cell differentiation | GO:0045577 | 23 | 0.132 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.129 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.127 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.124 | |
| cellular response to ionizing radiation | GO:0071479 | 11 | 0.121 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.119 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.119 | |
| dna methylation | GO:0006306 | 43 | 0.118 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.118 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.116 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.116 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.112 | |
| chromatin modification | GO:0016568 | 187 | 0.112 | |
| positive regulation of protein homooligomerization | GO:0032464 | 3 | 0.110 | |
| telomere maintenance in response to dna damage | GO:0043247 | 4 | 0.108 | |
| phosphatidylinositol 3 phosphate biosynthetic process | GO:0036092 | 6 | 0.107 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.106 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.104 | |
| nuclear division | GO:0000280 | 158 | 0.104 | |
| histone mrna metabolic process | GO:0008334 | 3 | 0.103 | |
| reciprocal meiotic recombination | GO:0007131 | 16 | 0.103 | |
| response to uv b | GO:0010224 | 5 | 0.103 | |
| microtubule based process | GO:0007017 | 236 | 0.103 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.102 | |
| response to radiation | GO:0009314 | 165 | 0.102 | |
| b cell homeostatic proliferation | GO:0002358 | 2 | 0.101 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.099 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.099 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.098 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.097 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.096 | |
| pre mirna processing | GO:0031054 | 3 | 0.095 | |
| meiosis i | GO:0007127 | 60 | 0.095 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.095 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.094 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.094 | |
| thymocyte apoptotic process | GO:0070242 | 19 | 0.093 | |
| response to inorganic substance | GO:0010035 | 96 | 0.093 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.093 | |
| response to gamma radiation | GO:0010332 | 22 | 0.092 | |
| rna catabolic process | GO:0006401 | 29 | 0.090 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.090 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.089 | |
| spermatogenesis | GO:0007283 | 284 | 0.089 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.088 | |
| response to alkaloid | GO:0043279 | 34 | 0.087 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.086 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.083 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.082 | |
| mitotic g1 dna damage checkpoint | GO:0031571 | 4 | 0.081 | |
| female sex differentiation | GO:0046660 | 84 | 0.079 | |
| fertilization | GO:0009566 | 127 | 0.078 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.078 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.078 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.077 | |
| negative regulation of lymphocyte apoptotic process | GO:0070229 | 24 | 0.077 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.076 | |
| cd4 positive cd25 positive alpha beta regulatory t cell differentiation | GO:0002361 | 4 | 0.076 | |
| regulation of histone modification | GO:0031056 | 56 | 0.074 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.074 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.074 | |
| retina homeostasis | GO:0001895 | 23 | 0.073 | |
| signal transduction involved in mitotic cell cycle checkpoint | GO:0072413 | 3 | 0.073 | |
| regulation of neuron death | GO:1901214 | 134 | 0.073 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.073 | |
| regulation of histone h3 k9 methylation | GO:0051570 | 8 | 0.072 | |
| regulation of t cell apoptotic process | GO:0070232 | 28 | 0.071 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.071 | |
| negative regulation of mammary gland epithelial cell proliferation | GO:0033600 | 3 | 0.071 | |
| positive regulation of b cell differentiation | GO:0045579 | 13 | 0.070 | |
| forebrain development | GO:0030900 | 302 | 0.069 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.068 | |
| cytoplasmic pattern recognition receptor signaling pathway in response to virus | GO:0039528 | 4 | 0.067 | |
| skeletal system development | GO:0001501 | 356 | 0.066 | |
| amine metabolic process | GO:0009308 | 45 | 0.065 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.065 | |
| pro b cell differentiation | GO:0002328 | 10 | 0.063 | |
| cellular response to x ray | GO:0071481 | 2 | 0.063 | |
| positive regulation of posttranscriptional gene silencing | GO:0060148 | 1 | 0.063 | |
| regulation of protein homooligomerization | GO:0032462 | 3 | 0.062 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.062 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.061 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.061 | |
| limb development | GO:0060173 | 166 | 0.061 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.061 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.061 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.060 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.060 | |
| organelle fission | GO:0048285 | 170 | 0.060 | |
| male meiosis i | GO:0007141 | 16 | 0.060 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.060 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.059 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.059 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.058 | |
| t cell differentiation | GO:0030217 | 174 | 0.057 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.057 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.056 | |
| schwann cell differentiation | GO:0014037 | 26 | 0.056 | |
| recombinational repair | GO:0000725 | 21 | 0.055 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.055 | |
| positive regulation of gamma delta t cell differentiation | GO:0045588 | 6 | 0.055 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.055 | |
| stem cell development | GO:0048864 | 219 | 0.055 | |
| neuron death | GO:0070997 | 154 | 0.055 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.055 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.055 | |
| protein acylation | GO:0043543 | 64 | 0.054 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.054 | |
| protein processing | GO:0016485 | 163 | 0.053 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.053 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.053 | |
| histone modification | GO:0016570 | 159 | 0.053 | |
| hyperosmotic salinity response | GO:0042538 | 1 | 0.052 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.052 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.051 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.051 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.050 | |
| appendage development | GO:0048736 | 166 | 0.050 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.049 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.049 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.049 | |
| rna processing | GO:0006396 | 105 | 0.048 | |
| gonad development | GO:0008406 | 141 | 0.048 | |
| muscle tissue development | GO:0060537 | 308 | 0.048 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.048 | |
| regulation of protein oligomerization | GO:0032459 | 4 | 0.048 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.048 | |
| telomere maintenance via telomerase | GO:0007004 | 1 | 0.047 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.047 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.047 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.047 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.047 | |
| positive regulation of mitotic sister chromatid separation | GO:1901970 | 2 | 0.047 | |
| long term synaptic potentiation | GO:0060291 | 25 | 0.046 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.046 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.046 | |
| adherens junction organization | GO:0034332 | 28 | 0.046 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.046 | |
| cellular response to water stimulus | GO:0071462 | 1 | 0.045 | |
| rig i signaling pathway | GO:0039529 | 4 | 0.045 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.045 | |
| action potential | GO:0001508 | 78 | 0.045 | |
| organ growth | GO:0035265 | 117 | 0.045 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.045 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.045 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.044 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.044 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.044 | |
| positive regulation of growth | GO:0045927 | 104 | 0.044 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.043 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.043 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.043 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.043 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.043 | |
| innate immune response | GO:0045087 | 157 | 0.043 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.043 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.042 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.042 | |
| multicellular organism growth | GO:0035264 | 161 | 0.042 | |
| chromosome segregation | GO:0007059 | 48 | 0.042 | |
| rna phosphodiester bond hydrolysis | GO:0090501 | 19 | 0.042 | |
| atp metabolic process | GO:0046034 | 75 | 0.042 | |
| cell aging | GO:0007569 | 35 | 0.042 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.041 | |
| positive regulation of release of cytochrome c from mitochondria | GO:0090200 | 5 | 0.041 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.041 | |
| positive regulation of protein autophosphorylation | GO:0031954 | 4 | 0.041 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.040 | |
| mrna metabolic process | GO:0016071 | 84 | 0.040 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.040 | |
| negative regulation of b cell proliferation | GO:0030889 | 13 | 0.040 | |
| rhythmic process | GO:0048511 | 174 | 0.039 | |
| regulation of b cell proliferation | GO:0030888 | 39 | 0.039 | |
| signal transduction involved in mitotic dna integrity checkpoint | GO:1902403 | 3 | 0.039 | |
| positive regulation of regulatory t cell differentiation | GO:0045591 | 4 | 0.039 | |
| dna dependent dna replication | GO:0006261 | 24 | 0.039 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.039 | |
| regulation of mitochondrial membrane permeability | GO:0046902 | 17 | 0.039 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.038 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.037 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.037 | |
| positive regulation of lymphocyte apoptotic process | GO:0070230 | 13 | 0.036 | |
| somatic hypermutation of immunoglobulin genes | GO:0016446 | 7 | 0.036 | |
| calcium ion transport | GO:0006816 | 159 | 0.036 | |
| regulation of protein localization | GO:0032880 | 231 | 0.036 | |
| negative regulation of b cell activation | GO:0050869 | 27 | 0.036 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.036 | |
| nuclear transcribed mrna catabolic process | GO:0000956 | 16 | 0.036 | |
| base excision repair | GO:0006284 | 9 | 0.036 | |
| ear development | GO:0043583 | 200 | 0.035 | |
| response to testosterone | GO:0033574 | 3 | 0.035 | |
| response to starvation | GO:0042594 | 65 | 0.034 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.034 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.034 | |
| positive regulation of transcription by galactose | GO:0000411 | 1 | 0.034 | |
| urogenital system development | GO:0001655 | 261 | 0.034 | |
| negative regulation of histone methylation | GO:0031061 | 10 | 0.034 | |
| mitochondrial dna repair | GO:0043504 | 3 | 0.034 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.034 | |
| negative regulation of dna dependent dna replication | GO:2000104 | 1 | 0.034 | |
| regulation of mitosis | GO:0007088 | 29 | 0.034 | |
| dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest | GO:0006977 | 3 | 0.034 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.034 | |
| regulation of muscle cell apoptotic process | GO:0010660 | 17 | 0.033 | |
| glycerophospholipid biosynthetic process | GO:0046474 | 32 | 0.032 | |
| metaphase plate congression | GO:0051310 | 2 | 0.032 | |
| mitochondrial outer membrane permeabilization involved in programmed cell death | GO:1902686 | 11 | 0.032 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.032 | |
| phospholipid biosynthetic process | GO:0008654 | 36 | 0.032 | |
| cell fate commitment | GO:0045165 | 210 | 0.032 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.032 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.031 | |
| sister chromatid cohesion | GO:0007062 | 12 | 0.031 | |
| somitogenesis | GO:0001756 | 69 | 0.031 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.031 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.031 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.031 | |
| response to oxidative stress | GO:0006979 | 123 | 0.031 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.031 | |
| nucleobase containing compound transport | GO:0015931 | 27 | 0.031 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.031 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.031 | |
| cellularization | GO:0007349 | 1 | 0.031 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.031 | |
| negative regulation of histone h3 k9 methylation | GO:0051573 | 4 | 0.030 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.030 | |
| intracellular signal transduction involved in g1 dna damage checkpoint | GO:1902400 | 3 | 0.030 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.030 | |
| somatic diversification of immune receptors via somatic mutation | GO:0002566 | 8 | 0.030 | |
| immune effector process | GO:0002252 | 321 | 0.030 | |
| positive regulation of mesoderm development | GO:2000382 | 2 | 0.030 | |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.029 | |
| metaphase anaphase transition of mitotic cell cycle | GO:0007091 | 9 | 0.029 | |
| fibroblast apoptotic process | GO:0044346 | 9 | 0.029 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.029 | |
| rna phosphodiester bond hydrolysis endonucleolytic | GO:0090502 | 10 | 0.029 | |
| positive regulation of histone h3 k4 methylation | GO:0051571 | 5 | 0.029 | |
| negative regulation of innate immune response | GO:0045824 | 17 | 0.029 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.029 | |
| zygote asymmetric cell division | GO:0010070 | 2 | 0.029 | |
| b cell lineage commitment | GO:0002326 | 4 | 0.029 | |
| dna biosynthetic process | GO:0071897 | 22 | 0.029 | |
| negative regulation of organ growth | GO:0046621 | 17 | 0.028 | |
| dna replication checkpoint | GO:0000076 | 2 | 0.028 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.028 | |
| positive regulation of mirna metabolic process | GO:2000630 | 1 | 0.028 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.028 | |
| regulation of cell division | GO:0051302 | 76 | 0.028 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.027 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.027 | |
| regulation of rig i signaling pathway | GO:0039535 | 2 | 0.027 | |
| thymus development | GO:0048538 | 41 | 0.027 | |
| neuronal action potential | GO:0019228 | 54 | 0.027 | |
| mitotic recombination | GO:0006312 | 3 | 0.027 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.027 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.027 | |
| rna 3 end processing | GO:0031123 | 20 | 0.027 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.027 | |
| male sex differentiation | GO:0046661 | 109 | 0.027 | |
| negative regulation of phosphatidylinositol 3 kinase activity | GO:0043553 | 1 | 0.027 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.027 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.027 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.027 | |
| muscle cell apoptotic process | GO:0010657 | 18 | 0.026 | |
| t cell activation | GO:0042110 | 289 | 0.026 | |
| mitotic spindle assembly checkpoint | GO:0007094 | 7 | 0.026 | |
| segmentation | GO:0035282 | 93 | 0.026 | |
| cellular response to increased oxygen levels | GO:0036295 | 1 | 0.026 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.026 | |
| response to drug | GO:0042493 | 75 | 0.026 | |
| response to oxygen levels | GO:0070482 | 62 | 0.026 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.026 | |
| gene silencing by rna | GO:0031047 | 19 | 0.025 | |
| signal transduction in response to dna damage | GO:0042770 | 21 | 0.025 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.025 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.025 | |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.025 | |
| positive regulation of response to dna damage stimulus | GO:2001022 | 14 | 0.025 | |
| photoreceptor cell maintenance | GO:0045494 | 19 | 0.025 | |
| activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:0097296 | 2 | 0.025 | |
| myelination | GO:0042552 | 74 | 0.025 | |
| cellular response to starvation | GO:0009267 | 57 | 0.024 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.024 | |
| protein catabolic process | GO:0030163 | 221 | 0.024 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.024 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.024 | |
| regionalization | GO:0003002 | 337 | 0.024 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.024 | |
| regulation of cell growth | GO:0001558 | 91 | 0.024 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.024 | |
| positive regulation of metaphase anaphase transition of cell cycle | GO:1902101 | 2 | 0.023 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.023 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.023 | |
| protein depolymerization | GO:0051261 | 34 | 0.023 | |
| germ line stem cell division | GO:0042078 | 2 | 0.023 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.023 | |
| mitotic sister chromatid separation | GO:0051306 | 9 | 0.023 | |
| cellular process regulating host cell cycle in response to virus | GO:0060154 | 3 | 0.023 | |
| response to peptide hormone | GO:0043434 | 127 | 0.023 | |
| nucleic acid transport | GO:0050657 | 18 | 0.022 | |
| cellular response to decreased oxygen levels | GO:0036294 | 18 | 0.022 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.022 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.022 | |
| dna geometric change | GO:0032392 | 7 | 0.022 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.022 | |
| modulation by virus of host morphology or physiology | GO:0019048 | 3 | 0.022 | |
| single fertilization | GO:0007338 | 82 | 0.022 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.022 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.022 | |
| glial cell development | GO:0021782 | 54 | 0.022 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.022 | |
| mitotic sister chromatid cohesion | GO:0007064 | 1 | 0.022 | |
| regulation of mitotic sister chromatid segregation | GO:0033047 | 12 | 0.022 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.021 | |
| blastocyst development | GO:0001824 | 80 | 0.021 | |
| b cell apoptotic process | GO:0001783 | 19 | 0.021 | |
| dna ligation | GO:0006266 | 3 | 0.021 | |
| positive regulation of myelination | GO:0031643 | 5 | 0.021 | |
| negative regulation of cellular protein catabolic process | GO:1903363 | 22 | 0.021 | |
| mrna catabolic process | GO:0006402 | 22 | 0.021 | |
| atp catabolic process | GO:0006200 | 55 | 0.021 | |
| regulation of mrna stability | GO:0043488 | 23 | 0.021 | |
| oocyte differentiation | GO:0009994 | 35 | 0.021 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.021 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.021 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.020 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.020 | |
| cellular hyperosmotic response | GO:0071474 | 0 | 0.020 | |
| postreplication repair | GO:0006301 | 5 | 0.020 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.020 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.020 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.020 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.020 | |
| rna localization | GO:0006403 | 23 | 0.020 | |
| viral process | GO:0016032 | 41 | 0.020 | |
| negative regulation of lipid kinase activity | GO:0090219 | 1 | 0.020 | |
| positive regulation of mammary gland involution | GO:1903521 | 4 | 0.020 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.020 | |
| cell division | GO:0051301 | 120 | 0.020 | |
| response to steroid hormone | GO:0048545 | 56 | 0.020 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.020 | |
| telencephalon development | GO:0021537 | 186 | 0.020 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.019 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.019 | |
| mesenchyme development | GO:0060485 | 152 | 0.019 | |
| organelle assembly | GO:0070925 | 177 | 0.019 | |
| maintenance of location | GO:0051235 | 89 | 0.019 | |
| mitochondrial membrane organization | GO:0007006 | 26 | 0.019 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.019 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.019 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.019 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.019 | |
| cellular response to light stimulus | GO:0071482 | 19 | 0.019 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.019 | |
| negative regulation of schwann cell proliferation | GO:0010626 | 1 | 0.019 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.019 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.019 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.019 | |
| negative regulation of thymocyte apoptotic process | GO:0070244 | 8 | 0.019 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.019 | |
| positive regulation of leukocyte apoptotic process | GO:2000108 | 21 | 0.019 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.019 | |
| dna conformation change | GO:0071103 | 37 | 0.019 | |
